Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 163.5
-1.39 %
$ 8.36 B
Market Cap
20.39
P/E
CRL - LONG-TERM DEBT
Long-term Debt CRL - Charles River Laboratories International, Inc.
3.07 B
LAST VALUE
-1.64%
2 YEAR CAGR
13.02%
5 YEAR CAGR
16.92%
10 YEAR CAGR